Kenji Mizumura

Nihon University — Japan

Medicine · Health Sciences

28h-index3.7kcitations113works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asthma and respiratory diseases(22), Autophagy in Disease and Therapy(19), Chronic Obstructive Pulmonary Disease (COPD) Research(15), Cancer, Hypoxia, and Metabolism(9), Metabolism and Genetic Disorders(9)

Publications113 total

Mitochondrial transplantation therapy using dedifferentiated fat cells for pulmonary fibrosis
2025
Establishment of IL-33 plus TSLP-induced human steroid-resistant asthma model using humanized mice and its potential application in preclinical research
2025
Novel Humanized Mouse Model for Steroid‐Resistant Asthma
Allergy·2025Open Access
Cigarette Smoke Extract–Induced Necroptosis Causes Mitochondrial DNA Release and Inflammation of Bronchial Epithelial Cells
International Journal of COPD·2025· 3 citedOpen Access
Gut Microbiota Dysbiosis in Japanese Female Patients with Nontuberculous Mycobacteria-Associated Lung Disease: An Observational Study
Biomedicines·2025· 2 citedOpen Access
Potential Biomarker for Predicting Clinical Remission Achieved by Mepolizumab in J-Real-Mepo Study
American Journal of Respiratory and Critical Care Medicine·2025· 1 cited
Therapeutic Effects of Intravenous Administration of Dedifferentiated Fat Cells in Pulmonary Fibrosis Mouse Model
American Journal of Respiratory and Critical Care Medicine·2025
Novel humanized mouse model for steroid-resistant asthma
2025
Real-world effectiveness of mepolizumab in Japanese asthma patients with diverse backgrounds: Improvements in rhinosinusitis imaging (J-Real-Mepo)
Allergology International·2025· 3 citedOpen Access
Advantage of spirometry over oscillometry to detect dupilumab's effect on small airway dysfunction
Allergology International·2025· 3 citedOpen Access
Prognostic significance of oxygen saturation/fraction of inspired oxygen 3 days after initiation of tocilizumab treatment in patients with COVID-19
Respiratory Investigation·2024Open Access
Effect of dupilumab on small airway dysfunction in real-life severe asthma: Japanese multi-center prospective cohort
2024
Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma
Allergology International·2024· 7 citedOpen Access
FeNO and Blood Eosinophils as Potential Predictive Biomarkers for Effectiveness of Dupilumab in Real-life Severe Asthma: Japanese Multi-center Prospective Cohort
2024
Anti-UBE2T antibody: A novel biomarker of progressive-fibrosing interstitial lung disease
Respiratory Investigation·2023· 1 cited
Supplementary Figure 4 from Autophagy-Dependent Metabolic Reprogramming Sensitizes TSC2-Deficient Cells to the Antimetabolite 6-Aminonicotinamide
2023Open Access
Data from Autophagy-Dependent Metabolic Reprogramming Sensitizes TSC2-Deficient Cells to the Antimetabolite 6-Aminonicotinamide
2023Open Access
Supplementary Figure 3 from Autophagy-Dependent Metabolic Reprogramming Sensitizes TSC2-Deficient Cells to the Antimetabolite 6-Aminonicotinamide
2023Open Access
Supplementary Figure 7 from Autophagy-Dependent Metabolic Reprogramming Sensitizes TSC2-Deficient Cells to the Antimetabolite 6-Aminonicotinamide
2023Open Access
Supplementary Figure Legend from Autophagy-Dependent Metabolic Reprogramming Sensitizes TSC2-Deficient Cells to the Antimetabolite 6-Aminonicotinamide
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Yasuhiro Gon(32), Shu Hashimoto(29), Shuichiro Maruoka(29), Augustine M.K. Choi(15), Mari Hikichi(12), Tetsuo Shimizu(9), Takashi Horie(8), Noriaki Takahashi(8), Suzanne M. Cloonan(7), Stefan W. Ryter(7), Yutaka Kozu(7), Yuko Iida(6), Sotaro Shikano(6), Mai Takahashi(5), Hidenori Ichijo(5), Fumio Kumasawa(5), Abhiram R. Bhashyam(4), Morgan Cervo(4), Caroline A. Owen(4), Ashfaq Mahmood(4)